Results 91 to 100 of about 24,877 (187)
Tryfon G Rotsos1, Marilita M Moschos21Medical Retina Service, Moorfields Eye Hospital, London, UK; 2Department of Ophthalmology, University of Athens, GreeceAbstract: We review the epidemiology, pathophysiology, and etiology of cystoid macular edema (CME)
Tryfon G Rotsos, Marilita M Moschos
doaj
Vitrectomy in diabetic macular edema [PDF]
Ramesh, Venkatesh +2 more
openaire +2 more sources
INTRODUCCIÓN: La prevalencia de la retinopatía diabética está determinada por el tipo de diabetes mellitus y por el tiempo de evolución de la enfermedad.
Eddy Mesa Hernández +4 more
doaj
Introduction: We report on one case of age-related macular degeneration and one case of diabetic macular edema with concomitant retinal arterial macroaneurysm (RAM) that were treated with anti-vascular endothelial growth factor (VEGF) intravitreal ...
Michiko Takamiya
doaj +1 more source
Background: The goal of this study was to determine the ratio of vascular endothelial growth factor (VEGF) to soluble VEGF receptor 1 (SVEGFR1) in aqueous humor of patients with non-proliferative diabetic retinopathy (NPDR).
Zahra Hasanpour +4 more
doaj
Diabetic macular edema (DME) is defined as the buildup of fluid within the retina in the extracellular space, specifically at the level of the macula in the inner nuclear, outer plexiform, Henle’s fiber layer, and subretinal space. Diabetes mellitus is one of the leading causes of visual impairment in industrialized countries and DME is the main reason
Emily D. Cole +2 more
openaire +2 more sources
Artificial intelligence in diabetic macular edema: Expanding clinical vision. [PDF]
Barigali A.
europepmc +1 more source
Efficacy and Safety of an Indian Bevacizumab BIOSimilar (BEVATAS) for Treatment-Naïve Diabetic Macular Edema (BIOS-DME Study). [PDF]
Chakraborty S +3 more
europepmc +1 more source
Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]
Ji M, Wei W, Gong H, Zhang G.
europepmc +1 more source

